MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    A Computer-Vision Based Method for Quantifying Parkinsonian Gait

    S. Rupprechter, G. Morinan, Y. Peng, J. O'Keeffe (London, United Kingdom)

    Objective: We proposed and evaluated a novel approach for estimating severity of gait impairment in Parkinson’s disease using a computer vision-based methodology. Background: Gait is…
  • MDS Virtual Congress 2021

    Functional connectivity predictive of efficacy for thalamic deep brain stimulation for Tourette Syndrome

    JC. Baldermann, C. Hennen, V. Visser-Vandewalle, D. Huys, M. Barbe (Cologne, Germany)

    Objective: To investigate whether outcome of thalamic deep brain stimulation (DBS) for Tourette Syndrome can be predicted by functional connectivity estimates seeding from individual stimulation sites.…
  • MDS Virtual Congress 2021

    Are we addressing the emotional burden? – recognition of mood disorders in patients with essential tremor

    G. Douglas, A. Doyle, S. Rafee, S. O'Riordan (Dublin, Ireland)

    Objective: To examine the assessment of non-motor symptoms in essential tremor in movement disorder clinics. Background: Essential tremor (ET) is one of the most common…
  • MDS Virtual Congress 2021

    Dysautonomia and cognitive impairment in Essential Tremor: is there a link?

    A. Rekik, A. Nasri, S. Mrabet, M. Bendjebara, A. Gargouri, I. Kacem, R. Gouider (Manouba, Tunisia)

    Objective: To investigate the relationship between autonomic dysfunction and cognitive impairment in Essential Tremor (ET). Background: Even though the term ‘essential’ was used to reflect…
  • MDS Virtual Congress 2021

    Towards a better understanding of social work practice in Parkinson’s disease care

    J. Shurer, T. Guan, L. Zerden, N. Browner, L. Kreitzer, E. Book (Chapel Hill, USA)

    Objective: To understand and document the roles and utilization of clinical social workers (SW) in the care of Parkinson’s disease (PD). Background: The importance of an interdisciplinary and evidence-based approach to…
  • MDS Virtual Congress 2021

    Spinocerebellar ataxia (SCA) type 2 and type 8: a tale of two repeat expansions in a single patient

    J. Frey, T. Tholanikunnel, L. Kugelmann, M. Burns, S. Subramony (Gainesville, USA)

    Objective: To describe the rare occurrence of coexisting SCA Types 2 and 8 in a pediatric patient. Background: SCAs are a group of autosomal dominant…
  • MDS Virtual Congress 2021

    Reversible hemichorea due to contralateral anterior cerebral artery territory hypoperfusion

    S. Adukia, P. Shah, M. Shrivastava, G. Sangani, D. Sanghvi, M. Bhatt, A. Aggarwal (Mumbai, India)

    Objective: We report hemichorea due to hypoperfusion of the contralateral anterior cerebral artery (ACA) territory (including caudate nucleus and its connections) that reversed with revascularization.…
  • MDS Virtual Congress 2021

    Pilot study to evaluate pimavanserin for the treatment of motor and behavioral symptoms of Tourette syndrome.

    A. Billnitzer, J. Jankovic (Houston, USA)

    Objective: To determine whether pimavanserin has an effect on motor and behavioral aspects of Tourette syndrome (TS). Background: Pimavanserin is a serotonin 2A receptor inverse…
  • MDS Virtual Congress 2021

    Carboplatin, Paclitaxel, and Nivolumab-induced Parkinsonism Responsive to Levodopa

    M. Branston, O. Tong (Sacramento, USA)

    Objective: To present the first reported case of reversible, levodopa sensitive, chemotherapy- induced parkinsonism due to the combination of carboplatin, paclitaxel, and nivolumab. Background: Many case reports describe antineoplastic agents causing reversible parkinsonism, most commonly, cyclophosphamide, cytosine arabinoside, and cyclosporine. To our knowledge, drug-induced parkinsonism related to combination therapy of paclitaxel, carboplatin, and nivolumab has never been…
  • MDS Virtual Congress 2021

    A Phase 3 Trial Evaluating the Efficacy, Duration of Effect, and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Cervical Dystonia

    J. Jankovic, C. Comella, R. Hauser, A. Patel, T. Gross, R. Rubio, D. Vitarella (Houston, USA)

    Objective: To evaluate the efficacy and safety of two doses of DaxibotulinumtoxinA for Injection (DAXI) vs placebo for treatment of cervical dystonia (CD). Background: DAXI…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley